|
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial |
|
|
|
Title: |
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial |
Author: |
Prince, H Miles Kim, Youn H Horwitz, Steven M Dummer, Reinhard Scarisbrick, Julia Quaglino, Pietro Zinzani, Pier Luigi Wolter, Pascal Sanches, Jose A Ortiz-Romero, Pablo L Akilov, Oleg E Geskin, Larisa Trotman, Judith Taylor, Kerry Dalle, Stephane Weichenthal, Michael Walewski, Jan Fisher, David Dréno, Brigitte Stadler, Rudolf Feldman, Tatyana Kuzel, Timothy M Wang, Yinghui Palanca-Wessels, Maria Corinna Zagadailov, Erin Trepicchio, William L Zhang, Wenwen Lin, Hui-Min Liu, Yi Huebner, Dirk Little, Meredith Whittaker, Sean Duvic, Madeleine |
Appeared in: |
Lancet |
Paging: |
Volume 390 (2017) nr. 10094 pages 12 p. |
Year: |
2017 |
Contents: |
|
Publisher: |
Elsevier Ltd |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|